Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists increase the risk of hair loss, mainly due to nutrient deficiency from weight loss.

GLP-1 receptor agonists can help manage PCOS metabolism but need careful use before conception.

GLP-1 receptor agonists can both help and harm hair, so careful monitoring is needed.

GLP-1 therapies, especially semaglutide and tirzepatide, may cause hair loss, particularly in women and with rapid weight loss.

Hair shedding is common in GLP-1 users, affecting treatment adherence.

GLP-1 receptor agonists may cause hair loss, but regrowth is rare.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

GLP-1 agonists may help treat certain skin conditions.

GLP-1 receptor agonists may cause hair loss, but more research is needed.

GLP-1 receptor agonists for weight loss may cause hair loss, especially in women.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

More research is needed to understand if GLP-1 agonists affect hair health.

Mice skin has components that could help with hair growth and might be used for diabetes treatment.

GLP-1 RA medications may be linked to hair loss.

Ganoderma lucidum may help treat enlarged prostate in rats.

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.

Tirzepatide may improve hair loss by reducing insulin resistance.

GLP-1 receptor agonists help women with PCOS lose weight and improve health, but more research is needed on long-term effects.

Semaglutide may cause hair loss, but more research is needed to confirm this.

Women with PCOS have a higher risk of heart disease.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

Metabolic issues may trigger lymphocytic cicatricial alopecia, and treatments targeting these issues could help.

GLP-1 receptor agonists may cause hair loss, but more research is needed.

PCOS and BED are linked, needing new treatment approaches focusing on mental health and eating habits.

Treating hirsutism and acne in women with PCOS needs a personalized approach using oral contraceptives, antiandrogens, and sometimes metformin.

PCOS is best managed with personalized lifestyle changes, medications, and sometimes surgery.

GLP-1 RAs may help wound healing but can also cause faster facial aging and skin issues.